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Paecilomyces lilacinus, a ubiquitous saprophytic mold found in the environment, is an emerging pathogen
that causes localized to severe systemic diseases, especially in immunocompromised patients. Thus far,
there are only eight reports on immunocompetent patients with cutaneous P. lilacinus in the English
literature. We herein present the case of an 87-year-old immunocompetent Taiwanese man who pre-
sented with a progressive, tender, erythematous plaque mimicking cellulitis on the ventral surface of the
right forearm for 2 weeks. The patient was initially diagnosed as a case of cellulitis; however, due to
unresponsiveness to the treatment for 1 week, we decided to perform skin biopsy and tissue culture.
Results of histopathologic analysis, tissue culture, and polymerase chain reaction assay indicated cuta-
neous P. lilacinus infection. Consequently, systemic antifungal treatment with oral itraconazole (200 mg/
d) was initiated and the skin lesion resolved after a 4-week treatment.
Copyright © 2015, Taiwanese Dermatological Association.
Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Paecilomyces species are saprophytic molds found ubiquitously in
the environment. Although they were deemed as laboratory con-
taminants in the past, recently there has been an increase in the
number of Paecilomyces-related infections. The most commonly
reported pathogenic species are Paecilomyces lilacinus, Paecilomyces
variotii, and Paecilomyces marquandii. Clinically, cutaneous and
subcutaneous infection was the second most common manifesta-
tion, following oculomycosis.1 Most of these cases were found in
immunocompromised patients who were under post-
transplantation status, with hematological malignancies or
AIDS.1e9 The main route of cutaneous infection reported in the
literature was direct cutaneous inoculation through the coloniza-
tion of clinical materials, such as applying contaminated skin lotionhave no ﬁnancial or nonﬁ-
tter or materials discussed in
gy, Taipei Veterans General
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ical Association. Published by Els
.or using incompletely sterilized central venous catheter, although
some patients contracted the infection through dog bite, contam-
inated water after ﬂooding, or wounds of mechanical trauma.1e3,10
Paecilomyces infection is an emerging hyalohyphomycosis in
humans, but there is relative inexperience in treating this infection.
In this paper, we present the case of a cutaneous P. lilacinus infec-
tion in an elderly but immunocompetent patient, who had been
successfully treatedwith oral itraconazole.We also reviewed all the
cases of cutaneous P. lilacinus infection in immunocompetent pa-
tients reported in English literature to provide treatment guidance
for physicians in the future.
Case Report
An 87-year-old Taiwanese man, with no known immunocompro-
mised status, presented with a progressive, tender, erythematous
plaque on the ventral surface of the right forearm for 2 weeks
(Figure 1A). Before the skin lesion developed, he alleged that there
were some itchy rashes over the area, and excoriated wounds due
to frequent scratching were noted by his daughter. Under the initial
impression of cellulitis, he was admitted to our hospital and
empiric treatment with intravenous oxacillin was initiated.evier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
Figure 1 (A) A cellulitis-like erythematous plaque on the ventral surface of the right forearm. (B) After oral itraconazole treatment (200 mg/d) for 4 weeks, the skin lesion resolved
drastically. (C) Nonpigmented, septated, branching hyphae demonstrated by periodic acideSchiff-diastase staining (original magniﬁcation 1000). (D) Morphological identiﬁcation
of Paecilomyces lilacinus: conidiophores with clustered tenpin-shaped phialides and round to oval nonbranching conidia (original magniﬁcation 400).
Y.-T. Chen, C.-C. Chen / Dermatologica Sinica 34 (2016) 33e3634Nevertheless, due to unresponsiveness to the treatment for 1 week,
we decided to perform skin biopsy and tissue culture to diagnose
the underlying condition. Histopathologic analysis of the skin
specimen revealed suppurative granulomas with pathogens
showing nonpigmented, septated, branching hyphae, which were
highlighted by periodic acideSchiff-diastase (PAS-D) stain
(Figures 1C and 1D). The tissue culture on Sabouraud dextrose agarFigure 2 (A) White ﬂoccus colonies with central brownish discoloration on the Sabouraud
the reverse side of the culture plate.(SDA) showed whitish ﬂoccose colonies with central lilac discol-
oration and brownish pigmentation on the reverse side of the
culture plate. However, due to the lack of malt extract agar in our
hospital, we did not demonstrate fungal culture result on it. The
fungal morphology under a microscope revealed erection of the
conidiophores with clustered tenpin-shaped phialides and round to
oval nonbranching conidia (Figures 1D, 2A, and 2B). The pathogendextrose agar culture plate. (B) Paecilomyces lilacinus shows brownish pigmentation on
Y.-T. Chen, C.-C. Chen / Dermatologica Sinica 34 (2016) 33e36 35was identiﬁed to be P. lilacinus. Moreover, we conducted polymer-
ase chain reaction with primers internal transcribed spacers 1
(ITS1) and ITS4 to amplify the ITS1, 5.8S RNA gene, and ITS2 regions
of the fungal DNA. The resulting sequence, composed of 573 nu-
cleotides, was compared with the public database (http://blast.
ncbi.nlm.nih.gov/Blast.cgi) and the results best matched with
P. lilacinus, showing 100% similarities. According to the ﬁnal diag-
nosis of cutaneous P. lilacinus infection, treatment with oral itra-
conazole (200 mg/d) was subsequently initiated and the
erythematous plaque on his right forearm resolved after a 4-week
treatment (Figure 1B).
Discussion
P. lilacinus is a saprophytic mold found ubiquitously in the envi-
ronment; however, it has now become an emerging pathogen
causing localized to severe systemic infection. Most of the re-
ported cases were under immunocompromised status and the
main predisposing factors included solid organ transplantation,
bone marrow transplantation, corticosteroid therapy, liver
cirrhosis, diabetes mellitus, AIDS, and primary immunodeﬁciency,
such as chronic granulomatous disease.1e9 However, an increasing
number of events occurring in healthy people had been reported
recently. This growing incidence strongly suggests that the path-
ogen P. lilacinus is no longer only an opportunistic pathogen and
that the worldwide disease burden could have been
underestimated.5,7,10e15
As the previous case reports demonstrated, the main route of
P. lilacinus cutaneous infection is direct inoculation and the possible
mediators were contaminated skin lotion, incompletely sterilized
central venous catheters, contaminated water after ﬂooding or
through the wounds of mechanical trauma.1e3,10 In our case, before
the current episode, the patient suffered from itchy eczematous
skin rashes over his bilateral forearms for an unknown period, and
excoriated wounds due to frequent scratching were noted by his
daughter. Therefore, the possible route of infection in our patient
might be direct fungal inoculation through contaminated hands
(repeated scratching of the wounds with his hand).
The clinical manifestation of cutaneous P. lilacinus infection
varies drastically, ranging from solitary or multiple disseminated
erythematous macules, papules, pustules, nodules, vesicles, and
ulcers to cellulitis-like plaques.1e15 As a result, accurate clinical
diagnosis of cutaneous P. lilacinus infection is extremely chal-
lenging for dermatologists. At present, the pathogen is identiﬁed byTable 1 Reported cases of cutaneous Paecilomyces lilacinus infection in immunocompete
Patient Study Age/sex Clinical presentations
1 Takayasu et al11 20/F Dark red scaly plaques on the left
4.6  5.0 cm
2 Cho et al12 19/M Erythematous patch with ﬁne scal
cheek
3 Hecker et al5 86/M Erythema & swelling of the left in
with a few small pustules
4 Gutierrez-Rodero et al13 36/M Lesion on the left leg
5 Gottlieb & Atkins14 59/F A tender nodule above the right la
malleolus
6 Hall et al7 65/M A bruise with pus formation & sur
papules over the left forearm
7 Zendri et al10 59/M Erythematous plaques on the right
of dog bite over the same area 3 m
8 Keshtkar-Jahromi et al15 60/F Painful swelling & intermittent ery
change over the 3rd metacarpopha
of the right hand
9 This case 87/M A tender erythematous plaque on
forearmhistopathologic analysis of the skin biopsy specimen, and tissue
culture is still the golden standard for the deﬁnite diagnosis. In
histopathology, nonpigmented, septated, branching hyphae with
adventitious sporulation could be accentuated by PAS-D stain. In
tissue culture, vinaceous to lilac ﬂoccus colonies develop on malt
extract agar due to sporulation of the fungi; however, on SDA,
brownish colonies develop.1 The morphology of P. lilacinus under a
microscope displays hyaline, rough-walled conidiophores with
clustered tenpin-shaped phialides and round to oval nonbranching
conidia.1e15
The optimal treatment for P. lilacinus infection is still unclear.
High minimum inhibitory concentration and minimum fungicidal
concentration of amphotericin B, ﬂucytosine, ﬂuconazole, ketoco-
nazole, and itraconazole were identiﬁed in previous studies for
treating P. lilacinus infection. By contrast, the pathogen was more
susceptible to the new-generation azoles, such as voriconazole and
posaconazole.16e18 Pastor and Guarro1 reported a high failure rate
in treating cutaneous P. lilacinus infection with systemic itracona-
zole in clinical practices after reviewing all the reported cases from
1964 to 2001. In the reviewed cases, there were 20 patients
suffering from cutaneous P. lilacinus infection who were treated by
oral itraconazole. Among them, two patients were immunocom-
petent, whereas the others were immunocompromised. Both
immunocompetent patients were cured with itraconazole (100%
response rate), whereas only two of the 18 immunocompromised
patients showed clinical response to the treatment (11.1% response
rate). Their result suggests that host factors, such as the immune
status, might play an important role in the efﬁcacy of the systemic
antifungal medication. Therefore, we reviewed previous studies
(English only) on the cutaneous P. lilacinus infection in immuno-
competent patients from 1997 to 2015 (Table 1).5,7,10e15 We iden-
tiﬁed a total of nine cases, including our present case. Among these
cases, ﬁve of six patients (83.33%) treated with oral itraconazole
were cured, except one patient who failed to respond to ﬂucona-
zole, itraconazole, and ketoconazole. Eventually, this patient was
cured by surgical excision. The reported treatment dosage of oral
itraconazole ranged from 200 mg/d to 400 mg/d and the treatment
course differed from 4 weeks to 6 months. Because the in vitro
susceptibility data of fungi might not be available in most hospitals,
oral itraconazole is considered the ﬁrst-line empiric therapy for
immunocompetent patients suffering from cutaneous P. lilacinus
infection.
In conclusion, P. lilacinus is a saprophytic mold that exists
ubiquitously in the environment; however, this has now become annt patients in English literature.
Treatment Outcome
cheek, 1% clotrimazole cream, then griseofulvin
(500 mg/d)
Failed
es on the left Griseofulvin (500 mg/d); 1% isoconazole for
6 wk failed; ketoconazole for 12 wk with
success
Cure
dex ﬁnger Oral itraconazole (400 mg/d) for 4 wk Cure
Oral itraconazole (200 mg/d) for 3 mo Cure
teral Oral itraconazole (200 mg/d) for 6 mo Cure
rounding red Poor response to itraconazole, ketoconazole, &
ﬂuconazole. Finally, removed by excision.
Presumed to
be cured
leg (wounds
o ago)
Oral itraconazole (400 mg/d) for 4 wk & then a
reduced dose (200 mg/d) for another 5 wk
Cure
thematous
langeal joint
Oral voriconazole for 3 mo Cure
the right Oral itraconazole (200 mg/d) for 4 wk Cure
Y.-T. Chen, C.-C. Chen / Dermatologica Sinica 34 (2016) 33e3636emerging pathogen in humans with variable clinical presentations
in both immunocompetent and immunocompromised patients.
Therefore, whenever a physician encounters refractory cellulitis-
like lesions that have poor response to empiric treatment, further
evaluations, including evaluating the patient's history of deep
fungal infection, are strongly recommended, even if the patient is
immunocompetent. Although more clinical data and experience
would be needed to identify the optimal treatment regimen for
cutaneous P. lilacinus infection, based on existing literature sources,
empiric oral itraconazole (200e400 mg/d) for at least four weeks
might be considered as the ﬁrst-line therapy for the immuno-
competent patients.References
1. Pastor FJ, Guarro J. Clinical manifestations, treatment and outcome of Paecilo-
myces lilacinus infections. Clin Microbiol Infect 2006;12:948e60.
2. Orth B, Frei R, Itin PH, et al. Outbreak of invasive mycoses caused by Paecilo-
myces lilacinus from a contaminated skin lotion. Ann Intern Med 1996;125:
799e806.
3. Itin PH, Frei R, Lautenschlager S, et al. Cutaneous manifestations of Paecilomyces
lilacinus infection induced by a contaminated skin lotion in patients who are
severely immunosuppressed. J Am Acad Dermatol 1998;39:401e9.
4. Blackwell V, Ahmed K, O'Docherty C, Hay RJ. Cutaneous hyalohyphomycosis
caused by Paecilomyces lilacinus in a renal transplant patient. Br J Dermatol
2000;143:873e5.
5. Hecker MS, Weinberg JM, Bagheri B, et al. Cutaneous Paecilomyces lilacinus
infection: report of two novel cases. J Am Acad Dermatol 1997;37:270e1.
6. Martin CA, Roberts S, Greenberg RN. Voriconazole treatment of disseminated
Paecilomyces infection in a patient with acquired immunodeﬁciency syndrome.
Clin Infect Dis 2002;35:e78e81.7. Hall VC, Goyal S, Davis MD, Walsh JS. Cutaneous hyalohyphomycosis caused by
Paecilomyces lilacinus: report of three cases and review of the literature. Int J
Dermatol 2004;43:648e53.
8. Van Schooneveld T, Freifeld A, Lesiak B, Kalil A, Sutton DA, Iwen PC. Paecilo-
myces lilacinus infection in a liver transplant patient: case report and review of
the literature. Transpl Infect Dis 2008;10:117e22.
9. Huang CY, Sun PL, Tseng HK. Cutaneous hyalohyphomycosis caused by Paeci-
lomyces lilacinus successfully treated by oral voriconazole and nystatin packing.
Mycopathologia 2011;172:141e5.
10. Zendri E, Martignoni G, Benecchi M, Fanti F, De Panﬁlis G. Paecilomyces lilacinus
cutaneous infection associated with a dog bite. J Am Acad Dermatol 2006;55:
S63e4.
11. Takayasu S, Akagi M, Shimizu Y. Cutaneous mycosis caused by Paecilomyces
lilacinus. Arch Dermatol 1977;113:1687e90.
12. Cho GY, Choo EH, Choi GJ, Hong NS, Houh W. Facial cutaneous mycosis by
Paecilomyces lilacinus. Korean J Dermatol 1984;22:89e93.
13. Gutierrez-Rodero F, Moragon M, Ortiz de la Tabla V, Mayol MJ, Martín C.
Cutaneous hyalohyphomycosis caused by Paecilomyces lilacinus in an immu-
nocompetent host successfully treated with itraconazole: case report and re-
view. Eur J Clin Microbiol Infect Dis 1999;18:814e8.
14. Gottlieb T, Atkins BL. Case report. Successful treatment of cutaneous Paecilo-
myces lilacinus infection with oral itraconazole in an immune competent host.
Mycoses 2001;44:513e5.
15. Keshtkar-Jahromi M, McTighe AH, Segalman KA, Fothergill AW, Campbell WN.
Unusual case of cutaneous and synovial Paecilomyces lilacinus infection of hand
successfully treated with voriconazole and review of published literature.
Mycopathologia 2012;174:255e8.
16. Aguilar C, Pujol I, Sala J, Guarro J. Antifungal susceptibilities of Paecilomyces
species. Antimicrob Agents Chemother 1998;42:1601e4.
17. Castelli MV, Alastruey-Izquierdo A, Cuesta I, et al. Susceptibility testing and
molecular classiﬁcation of Paecilomyces spp. Antimicrob Agents Chemother
2008;52:2926e8.
18. Antas PR, Brito MM, Peixoto E, Ponte CG, Borba CM. Neglected and emerging
fungal infections: review of hyalohyphomycosis by Paecilomyces lilacinus
focusing in disease burden, in vitro antifungal susceptibility and management.
Microbes Infect 2012;14:1e8.
